Paul Fehlner

Paul Fehlner

Corporate Officer/Principal chez SPYRE THERAPEUTICS, INC.
63 ans
Commercial Services
Health Technology
Consumer Services

Profil

Paul Fehlner was the founder of Life Sciences Innovation LLC, founded in 2017, holding the title of Principal.
Dr. Fehlner is also the founder of ReVision Therapeutics, Inc...
Dr. Fehlner is Senior VP & Chief Intellectual Property Counsel at Spyre Therapeutics, Inc. since 2023.
Former positions include Associate & Principal at Darby & Darby, Associate at Klauber & Jackson Llc, Global Head-Intellectual Property at Novartis Pharma AG from 2008 to 2017, Secretary, Chief Legal Officer & Senior VP at Axcella Health, Inc. from 2021 to 2023, and Partner at Baker Botts LLP from 2006 to 2008.
Education includes graduate degree from Fordham University in 1994, undergraduate degree from Haverford College in 1985, and doctorate from The Rockefeller University in 1990.

Postes actifs de Paul Fehlner

SociétésPosteDébut
SPYRE THERAPEUTICS, INC. Corporate Officer/Principal 27/11/2023

Anciens postes connus de Paul Fehlner

SociétésPosteFin
AXCA HEALPAR Conseiller Juridique Général 01/11/2023
Corporate Officer/Principal 01/11/2017
Corporate Officer/Principal 01/01/2008
Fondateur -
Corporate Officer/Principal -
Voir l'expérience en détail de Paul Fehlner

Formation de Paul Fehlner

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

88

Relations au 1er degré

11

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées11

Retail Trade

Health Technology

Commercial Services

Commercial Services

Consumer Services

Consumer Services

Consumer Services

Commercial Services

Health Technology

Health Technology

Life Sciences Innovation LLC

  1. Bourse
  2. Insiders
  3. Paul Fehlner
-40% : Prolongation exceptionnelle ➤➤➤➤
j
:
:
PROFITEZ-EN MAINTENANT
🔇